Related Experiment Videos
[Surgery of insulinoma]
1Clinique Chirurgicale Adultes EST, Service de Chirurgie Générale et endocrinienne, CHU de Lille, France.
Acta Chirurgica Belgica
|March 1, 1991
Summary
Pre-operative imaging for insulinomas is recommended, but surgery should proceed if diagnosis is certain. Diazoxide trials can guide therapy and potentially avoid surgery in select patients.
Area of Science:
- Endocrinology
- Surgical Oncology
Context:
- Insulinomas require careful pre-operative assessment and surgical planning.
- Accurate tumor localization is essential for successful surgical outcomes.
Purpose:
- To outline optimal diagnostic and surgical strategies for insulinoma management.
- To emphasize the importance of pre-operative evaluation and intra-operative monitoring.
Summary:
- Pre-operative imaging is recommended, but negative studies should not preclude laparotomy if diagnosis is certain. A Diazoxide trial is mandatory to assess therapeutic response and guide surgical decisions, potentially avoiding blind pancreatic resection.
- Intra-operative monitoring of blood glucose, palpation, echography, and portal sampling aid tumor localization. Conservative resection like enucleation is preferred, especially for tumors in the pancreatic head. Spleen preservation is key in left pancreatic resections.
- Confirmation of complete tumor removal relies on hyperglycemic rebound and decreased insulin levels. Surgery for liver metastases is generally not indicated; chemotherapy and SMS-analogs offer palliative options.
Impact:
- Improved surgical decision-making and reduced unnecessary procedures.
- Enhanced patient outcomes through tailored treatment and precise surgical techniques.
- Provides a comprehensive guide for managing complex insulinoma cases.